Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength
Nutrients · 02.01.2025 · 17 (1) · 178
DOI: 10.3390/nu17010178 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 02.01.2025. Verfasst von Dana Crişan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Sarcopenia, Fatty Liver. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The connections between sarcopenia and various chronic conditions, including type 2 diabetes (T2DM), metabolic syndrome (MetS), and liver disease have been highlighted recently. There is also a high occurrence of sarcopenia in metabolic dysfunction-associated steatotic liver disease (MASLD) patients, who are often disregarded. Both experimental and clinical findings suggest a complex, bidirectional relationship between MASLD and sarcopenia. While vitamin D, testosterone, and specific drug therapies show promise in mitigating sarcopenia, consensus on effective treatments is lacking. Recent focus on lifestyle interventions emphasizes dietary therapy and exercise for sarcopenic obesity in MASLD. Challenges arise as weight loss, a primary MASLD treatment, may lead to muscle mass reduction. The therapeutic approach to sarcopenia in morbidly obese MASLD patients also includes bariatric surgery (BS). BS induces weight loss and stabilizes metabolic imbalances, but its impact on sarcopenia is nuanced, underscoring the need for further research. Our aim is to provide a comprehensive review of the interplay between sarcopenia and MASLD and offer insight into the most recent therapeutic challenges and discoveries, as sarcopenia is often overlooked or unrecognized and poses significant challenges for managing these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- Clinical Municipal Hospital, 400139 Cluj-Napoca, Romania.
- Regional Institute of Gastroenterology and Hepatology "Prof. Dr. Octavian Fodor", 400162 Cluj-Napoca, Romania.
ORCID-Profile: Dana Crişan, Lucreţia Avram, Rareş Crăciun, Valer Donca, Andrada Nemeş
Zitieren
APA
Crişan, D., Avram, L., Morariu-Barb, A., Grapa, C., Hirişcau, I., Crăciun, R., Donca, V., & Nemeş, A. (2025). Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength. Nutrients, 17(1), 178. https://doi.org/10.3390/nu17010178
Vancouver
Crişan D, Avram L, Morariu-Barb A, Grapa C, Hirişcau I, Crăciun R, et al. Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength. Nutrients. 2025;17(1):178. doi:10.3390/nu17010178
BibTeX
@article{Crian2025,
author = {Crişan, Dana and Avram, Lucreţia and Morariu-Barb, Andreea and Grapa, Cristiana and Hirişcau, Ioana and Crăciun, Rareş and Donca, Valer and Nemeş, Andrada},
title = {Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {1},
pages = {178},
doi = {10.3390/nu17010178}
}
EUVIMED